HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study.

Abstract
112 patients admitted to hospital with a diagnosis of erysipelas, were randomized to 8 days treatment with prednisolone or placebo in addition to antibiotics. 108 patients received the study drugs and were evaluated for time to cure, which was the primary end-point. The median healing time was significantly shorter in the prednisolone group, 5 days, vs 6 days in the placebo group (p < 0.01). The 90th percentile healing time was 10.0 days in the prednisolone group vs 14.6 days in the control group. The prednisolone-treated patients had a median length of hospital stay (secondary end-point) of 5 days vs 6 for the placebo-treated (p < 0.01). The median treatment time with intravenous antibiotics (secondary end-point) was 4 days in the placebo group, which was 1 day longer than in the prednisolone group (p < 0.05). 13 patients, 7 of whom received placebo, relapsed during the observation period of 3 weeks. The frequency of side effects attributable to the study drug was not higher in the prednisolone group.
AuthorsP I Bergkvist, K Sjöbeck
JournalScandinavian journal of infectious diseases (Scand J Infect Dis) Vol. 29 Issue 4 Pg. 377-82 ( 1997) ISSN: 0036-5548 [Print] England
PMID9360253 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Penicillins
  • Prednisolone
Topics
  • Anti-Inflammatory Agents (administration & dosage, adverse effects, therapeutic use)
  • Bacteremia (diagnosis)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Erysipelas (drug therapy)
  • Female
  • Hospitalization
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Penicillins (administration & dosage, therapeutic use)
  • Prednisolone (administration & dosage, adverse effects, therapeutic use)
  • Recurrence
  • Staphylococcal Infections (blood, diagnosis)
  • Staphylococcus aureus (growth & development)
  • Streptococcal Infections (blood, diagnosis)
  • Streptococcus (growth & development)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: